IL217740B - Method to improve virus removal in protein purification - Google Patents

Method to improve virus removal in protein purification

Info

Publication number
IL217740B
IL217740B IL217740A IL21774012A IL217740B IL 217740 B IL217740 B IL 217740B IL 217740 A IL217740 A IL 217740A IL 21774012 A IL21774012 A IL 21774012A IL 217740 B IL217740 B IL 217740B
Authority
IL
Israel
Prior art keywords
viruses
proteins
purification
removal
improve
Prior art date
Application number
IL217740A
Other languages
English (en)
Hebrew (he)
Other versions
IL217740A0 (en
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42985499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL217740(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL217740A0 publication Critical patent/IL217740A0/en
Publication of IL217740B publication Critical patent/IL217740B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL217740A 2009-08-06 2012-01-26 Method to improve virus removal in protein purification IL217740B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23181109P 2009-08-06 2009-08-06
PCT/US2010/044760 WO2011031397A1 (en) 2009-08-06 2010-08-06 Method to improve virus removal in protein purification

Publications (2)

Publication Number Publication Date
IL217740A0 IL217740A0 (en) 2012-03-29
IL217740B true IL217740B (en) 2020-04-30

Family

ID=42985499

Family Applications (3)

Application Number Title Priority Date Filing Date
IL217740A IL217740B (en) 2009-08-06 2012-01-26 Method to improve virus removal in protein purification
IL273486A IL273486B (en) 2009-08-06 2020-03-22 A method to improve the removal of viruses in the purification of proteins
IL287431A IL287431A (en) 2009-08-06 2021-10-20 A method to improve the removal of viruses in the purification of proteins

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL273486A IL273486B (en) 2009-08-06 2020-03-22 A method to improve the removal of viruses in the purification of proteins
IL287431A IL287431A (en) 2009-08-06 2021-10-20 A method to improve the removal of viruses in the purification of proteins

Country Status (25)

Country Link
US (5) US10662237B2 (de)
EP (3) EP4559926A3 (de)
JP (6) JP2013501075A (de)
KR (3) KR20190018041A (de)
CN (2) CN102712691A (de)
AU (1) AU2010292897B2 (de)
BR (1) BR112012002574A2 (de)
CA (1) CA2770235C (de)
DK (1) DK2462158T3 (de)
ES (1) ES2662529T3 (de)
HR (1) HRP20180309T1 (de)
HU (1) HUE038451T2 (de)
IL (3) IL217740B (de)
LT (1) LT2462158T (de)
MX (1) MX346115B (de)
MY (1) MY188566A (de)
NO (1) NO2462158T3 (de)
NZ (1) NZ597809A (de)
PL (1) PL2462158T3 (de)
PT (1) PT2462158T (de)
RU (1) RU2573894C2 (de)
SG (1) SG178276A1 (de)
SI (1) SI2462158T1 (de)
WO (1) WO2011031397A1 (de)
ZA (1) ZA201200626B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2842964A1 (en) 2006-09-13 2008-03-20 Abbvie Inc. Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
AU2009307737B2 (en) 2008-10-20 2015-07-23 Abbvie Inc. Viral inactivation during purification of antibodies
NZ592095A (en) 2008-10-20 2013-01-25 Abbott Lab Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
SI2462158T1 (en) * 2009-08-06 2018-04-30 F. Hoffmann-La Roche Ag Method to improve virus removal in protein purification
TW201302793A (zh) 2010-09-03 2013-01-16 Glaxo Group Ltd 新穎之抗原結合蛋白
RU2013147609A (ru) * 2011-03-25 2015-04-27 Дженентек, Инк. Новые способы очистки белка
DE102011105525B4 (de) * 2011-06-24 2015-03-26 Sartorius Stedim Biotech Gmbh Verfahren zur Abtrennung von Biopolymer-Aggregaten und Viren aus einem Fluid
WO2013028330A2 (en) 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
HRP20181846T1 (hr) 2011-12-22 2018-12-28 Genentech, Inc. Kromatografija membranom za ionsku izmjenu
NZ756750A (en) 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
ES2915378T3 (es) 2013-09-13 2022-06-22 Hoffmann La Roche Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares
MX383595B (es) * 2014-10-21 2025-03-14 Gennova Biopharmaceuticals Ltd Proceso novedoso de purificacion para el aislamiento y produccion comercial de tnk-tpa recombinante (tenecteplasa)
JP7133925B2 (ja) * 2015-03-23 2022-09-09 アレクシオン ファーマシューティカルズ インコーポレイテッド ウイルス濾過
WO2018230397A1 (ja) * 2017-06-12 2018-12-20 旭化成メディカル株式会社 タンパク質含有液のろ過方法
EP3728288B1 (de) * 2017-12-21 2022-01-19 Genzyme Corporation Verfahren zur verbesserten entfernung von verunreinigungen während der protein-a-chromatographie
TWI871300B (zh) * 2019-01-28 2025-02-01 美商安進公司 藉由將藥物物質和藥物產品過程整體化的生物製劑製造之連續製造過程

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
WO1981001145A1 (en) 1979-10-18 1981-04-30 Univ Illinois Hydrolytic enzyme-activatible pro-drugs
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
ES2058199T3 (es) 1987-09-23 1994-11-01 Bristol Myers Squibb Co Heteroconjugados de anticuerpos para la eliminacion de celulas infectadas por el vih.
JPH04501201A (ja) 1987-12-21 1992-03-05 ジ・アップジョン・カンパニー 発芽植物種子類のアグロバクテリウム媒介形質転換
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
JPH02198687A (ja) 1989-01-26 1990-08-07 Asahi Chem Ind Co Ltd 純水の製造方法
JPH038759A (ja) 1989-03-16 1991-01-16 Sumitomo Metal Ind Ltd 半導体磁器物質
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
DE69029036T2 (de) 1989-06-29 1997-05-22 Medarex Inc Bispezifische reagenzien für die aids-therapie
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
EP0586505A1 (de) 1991-05-14 1994-03-16 Repligen Corporation Heterokonjugat-antikörper zur behandlung von hiv-infektionen
EP0940468A1 (de) 1991-06-14 1999-09-08 Genentech, Inc. Änderliches Gebiet einer humanisierter Antikörper
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
EP0617706B1 (de) 1991-11-25 2001-10-17 Enzon, Inc. Multivalente antigen-bindende proteine
JPH08500017A (ja) 1992-08-17 1996-01-09 ジェネンテク，インコーポレイテッド 二特異的免疫アドヘジン
EP0812200B1 (de) * 1993-07-09 2002-02-27 Avant Immunotherapeutics, Inc. Proteinreinigung
JP4057049B2 (ja) * 1993-09-21 2008-03-05 ヘモソル インコーポレーテッド 置換クロマトグラフィー法および精製ヘモグロビン産物
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
JP3415222B2 (ja) 1993-10-20 2003-06-09 東洋濾紙株式会社 エンドトキシン吸着能を有するポリエーテルサルホン又はスルホン化ポリエーテルサルホン微孔膜
JP3453623B2 (ja) 1994-03-30 2003-10-06 サンスター株式会社 エンドトキシン吸着除去剤および除去方法
WO1996003202A1 (en) 1994-07-28 1996-02-08 Millipore Corporation Porous composite membrane and process
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
FR2737730B1 (fr) * 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
DE59709915D1 (de) * 1996-02-06 2003-05-28 Roche Diagnostics Gmbh Verfahren zur herstellung von gereinigter nukleinsäure und deren verwendung
TW505655B (en) 1997-10-14 2002-10-11 Tanox Inc Enhanced aggregate removal from bulk-biologicals using ion exchange chromatography
GB9907553D0 (en) * 1999-04-01 1999-05-26 Cantab Pharma Res Purification of biological preparations
DK1200179T3 (da) 1999-07-30 2006-09-25 Genentech Inc Ladede filtreringsmembraner og anvendelser deraf
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
US6806355B2 (en) 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
US7118675B2 (en) * 2002-02-04 2006-10-10 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
HUE025101T2 (en) 2002-04-26 2016-02-29 Genentech Inc Purification of proteins other than affinity purification
SI1545574T1 (sl) 2002-09-13 2014-10-30 Biogen Idec Inc. Postopek za čiščenje polipeptidov s simulirano "moving bed" kromatografijo
EP1403274A1 (de) 2002-09-30 2004-03-31 Meristem Therapeutics Verfahren zur Reinigung von rekombinanten Proteinen aus komplexen Medien sowie die auf diese Weise erhaltenen gereinigten Proteine
US20040116676A1 (en) 2002-09-30 2004-06-17 Hotta Joann Methods for removal of contaminants from blood product solutions
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
WO2004087761A1 (ja) 2003-03-31 2004-10-14 Kirin Beer Kabushiki Kaisha ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
KR101224235B1 (ko) 2003-04-11 2013-01-25 메디뮨 엘엘씨 재조합 ｉｌ­９ 항체 및 그의 용도
SI2418220T1 (sl) * 2003-12-10 2017-10-30 E. R. Squibb & Sons, L.L.C. Interferon alfa protitelesa in njihova uporaba
EP2532742B1 (de) 2004-01-30 2018-08-08 Shire Pharmaceuticals Ireland Limited Rekombinanter Arylsulfatase A zur ZUR Verringerung des Galaktosyl Sulphatidegehalts
KR20070009995A (ko) * 2004-01-30 2007-01-19 수오멘 푸나이넨 리스티 베리팔베루 바이러스 안전성 면역글로불린을 제조하는 방법
US7390403B2 (en) 2004-03-19 2008-06-24 Millipore Corporation Prefilter system for biological systems
WO2006042541A1 (en) 2004-10-21 2006-04-27 Statens Serum Institut A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method
JP2006249082A (ja) * 2005-03-08 2006-09-21 Pharmacia & Upjohn Co Llc 低減レベルの内毒素を有する抗ｍ−ｃｓｆ抗体組成物
KR20080111487A (ko) * 2006-03-20 2008-12-23 메다렉스, 인코포레이티드 단백질 정제 방법
EP1854810A1 (de) 2006-05-09 2007-11-14 PanGenetics B.V. De-immunisierter und antagonister monoclonaler Antikörper gegen CD40, der aus der ch5D12 Antikörper abgeleitet ist
EP2069387A4 (de) * 2006-06-14 2011-02-02 Glaxosmithkline Llc Verfahren zur reinigung von antikörpern mithilfe von keramik-hydroxyapatit
US20100267932A1 (en) 2006-08-28 2010-10-21 Alex Eon-Duval Process for the purification of fc-fusion proteins
WO2008036899A2 (en) 2006-09-22 2008-03-27 Amgen Inc. Methods for removing viral contaminants during protein purification
DK2087002T3 (da) 2006-10-27 2014-10-27 Lpath Inc Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat
WO2008073620A2 (en) 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
SI2078071T1 (sl) 2006-11-08 2015-05-29 Wyeth Llc Racionalno zasnovana gojišča za celično kulturo
CN105567627B (zh) 2007-04-26 2020-09-29 中外制药株式会社 使用含高浓度氨基酸的培养基的细胞培养方法
BRPI0820604A2 (pt) 2007-12-21 2017-05-09 Genentech Inc método de purificação de um anticorpo cd20, cristal de um anticorpo cd20, composição e método destinado ao tratamento de uma condição ou doença associada ao cd20
JP2011523408A (ja) 2008-05-15 2011-08-11 ノボ・ノルデイスク・エー／エス 抗体精製方法
CN102365368B (zh) * 2009-03-27 2014-07-30 旭化成医疗株式会社 高浓度单克隆抗体溶液中的病毒去除方法
MX2011012576A (es) 2009-05-27 2012-05-08 Baxter Int Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo.
SI2462158T1 (en) 2009-08-06 2018-04-30 F. Hoffmann-La Roche Ag Method to improve virus removal in protein purification
CN102686738A (zh) 2009-09-01 2012-09-19 弗·哈夫曼-拉罗切有限公司 通过改进的a蛋白洗脱增强的蛋白质纯化

Also Published As

Publication number Publication date
JP2017206529A (ja) 2017-11-24
LT2462158T (lt) 2018-03-26
JP2016106096A (ja) 2016-06-16
US20200347118A1 (en) 2020-11-05
KR20190018041A (ko) 2019-02-20
EP2462158B1 (de) 2018-01-10
EP4559926A2 (de) 2025-05-28
KR101844859B1 (ko) 2018-05-18
US20110034674A1 (en) 2011-02-10
IL217740A0 (en) 2012-03-29
SI2462158T1 (en) 2018-04-30
IL287431A (en) 2021-12-01
KR20130051431A (ko) 2013-05-20
WO2011031397A1 (en) 2011-03-17
US20250282850A1 (en) 2025-09-11
JP2013501075A (ja) 2013-01-10
JP2020023491A (ja) 2020-02-13
US11225513B2 (en) 2022-01-18
CA2770235A1 (en) 2011-03-17
MY188566A (en) 2021-12-22
HRP20180309T1 (hr) 2018-03-23
US20220306726A1 (en) 2022-09-29
HUE038451T2 (hu) 2018-10-29
ZA201200626B (en) 2013-06-26
AU2010292897B2 (en) 2016-01-07
EP3309168A1 (de) 2018-04-18
IL273486B (en) 2022-04-01
US10662237B2 (en) 2020-05-26
RU2012108318A (ru) 2013-09-20
DK2462158T3 (en) 2018-03-05
MX346115B (es) 2017-03-08
JP2025003999A (ja) 2025-01-14
CA2770235C (en) 2021-06-29
AU2010292897A1 (en) 2012-02-16
ES2662529T3 (es) 2018-04-06
US20240083980A1 (en) 2024-03-14
BR112012002574A2 (pt) 2020-11-03
KR20180035936A (ko) 2018-04-06
PL2462158T3 (pl) 2018-05-30
RU2573894C2 (ru) 2016-01-27
EP2462158A1 (de) 2012-06-13
PT2462158T (pt) 2018-02-23
NZ597809A (en) 2014-05-30
MX2012001659A (es) 2012-04-30
IL273486A (en) 2020-05-31
JP2023029853A (ja) 2023-03-07
CN102712691A (zh) 2012-10-03
SG178276A1 (en) 2012-03-29
EP4559926A3 (de) 2025-08-06
NO2462158T3 (de) 2018-06-09
CN106905413A (zh) 2017-06-30

Similar Documents

Publication Publication Date Title
IL217740B (en) Method to improve virus removal in protein purification
FR16C1026I2 (fr) Inhibiteurs de la replication du virus de l'hepatite c
BR112013024521A2 (pt) métodos de purificação de proteínas
BRPI1009447A2 (pt) métodos de purificação de proteínas imunofarmacêuticas modulares pequenas
DK2401046T3 (da) Separationsfremgangsmåde
DK2598514T3 (da) Proteinoprensning
BR112012031513A2 (pt) processo para purificar um gás natural
BR112012000822A2 (pt) processo
BR112012012338A2 (pt) processo
DK2598516T3 (da) Fremgangsmåde til proteinoprensning
EP2519636A4 (de) Herstellung eines hämagglutinin-neuraminidase-proteins in mikroalgen
BR112012009097A2 (pt) processo para produzir colagens
BRPI1007573A2 (pt) processo
EP2519537A4 (de) Reinigung von proteinen
BRPI0908337A2 (pt) Método para purificar ácido metacrílico
EP2697245A4 (de) Verfahren zur aufreinigung von hydrophobin
BR112012003642A2 (pt) processo
BRPI1008654A2 (pt) processo para purificação de guar
FI20100120A0 (fi) Reaktori ja menetelmä prosessiliuoksen puhdistamiseksi
BR112013013038A2 (pt) processo de purificação de biodiesel e biodiesel assim obtido
IT1402514B1 (it) Metodo di purificazione e metodo per produrre un vaccino
DK2393834T3 (da) Fremgangsmåde til oprensning
BR112013005946A2 (pt) processo de purificação de glicerol bruto
FI20095795A0 (fi) Menetelmä biologiseen puhdistamiseen
FI20105862A0 (fi) Menetelmä hekseeniuronihappojen poistamiseksi

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed